Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Purpose: Human amnion epithelial cells (hAECs) are nonimmunogenic, nontumorigenic, anti-inflammatory cells normally discarded with placental tissue. We reasoned that their profile of biological features, wide availability, and the lack of ethical barriers to their use could make these cells useful as a therapy in ischemic stroke.

Methods: We tested the efficacy of acute (1.5 hours) or delayed (1-3 days) poststroke intravenous injection of hAECs in 4 established animal models of cerebral ischemia. Animals included young (7-14 weeks) and aged mice (20-22 months) of both sexes, as well as adult marmosets of either sex.

Results: We found that hAECs administered 1.5 hours after stroke in mice migrated to the ischemic brain via a CXC chemokine receptor type 4-dependent mechanism and reduced brain inflammation, infarct development, and functional deficits. Furthermore, if hAECs administration was delayed until 1 or 3 days poststroke, long-term functional recovery was still augmented in young and aged mice of both sexes. We also showed proof-of-principle evidence in marmosets that acute intravenous injection of hAECs prevented infarct development from day 1 to day 10 after stroke.

Conclusions: Systemic poststroke administration of hAECs elicits marked neuroprotection and facilitates mechanisms of repair and recovery.

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.117.019136DOI Listing

Publication Analysis

Top Keywords

human amnion
8
amnion epithelial
8
epithelial cells
8
days poststroke
8
intravenous injection
8
injection haecs
8
aged mice
8
infarct development
8
haecs
6
acute delayed
4

Similar Publications

Introduction: Monkeypox (mpox) is an emerging infectious disease with increasing global incidence. Limited evidence exists regarding its impact on pregnancy and perinatal outcomes, especially in low-resource settings. The objective was to systematically synthesize current evidence on maternal and fetal outcomes associated with mpox infection during pregnancy.

View Article and Find Full Text PDF

Although many preclinical and clinical studies are ongoing on amniotic membrane extract (AME), an amniotic membrane-derived product developed to support ocular surface healing, the effect of AME on the basic cellular functions and properties of human corneal epithelial cells (hCECs) has not been clearly defined. In this study, we aimed to evaluate the effect of AME supplementation to the culture media, on basic cellular functions of hCECs and on expression of specific cell markers of hCECs, as well as to determine its effectiveness in an experimental in vitro wound model. hCECs were seeded with the constant cell density in 6, 24 and 48 well plates.

View Article and Find Full Text PDF

Background: A growing body of evidence from primate embryos as well as in vitro systems supports the notion that amnion and primordial germ cell (PGC) lineage progressing cells share a common precursor.

Results: To gain comprehensive transcriptomic insights into this critical but poorly understood precursor and its progeny, we examine the evolving transcriptome of a developing human pluripotent stem cell-derived model of amnion and PGC formation at the single cell level. This analysis reveals several continuous amniotic fate progressing states with state-specific markers.

View Article and Find Full Text PDF

Intraamniotic hemorrhage: challenges in prenatal detection: a case report.

BMC Pregnancy Childbirth

September 2025

Department of Gynecology & Obstetrics, Liaocheng People's Hospital, Dongchang Street 67, Liaocheng, China.

Background: Subamniotic hemorrhage, a rare condition involving bleeding between the amniotic membrane and fetal chorionic plate, presents diagnostic challenges.

Case Presentation: A 35-year-old woman at 37 weeks of gestation who presented with lower abdominal discomfort and decreased fetal movements came to our emergency department. Ultrasound revealed medium-strong echoes in the amniotic fluid and inhomogeneous echoes around the umbilical cord.

View Article and Find Full Text PDF

Ontogenetic stage and type of donor cells shape extracellular vesicles' therapeutic potential for osteoarthritis.

Stem Cell Res Ther

September 2025

Department for Small Animals and Horses, Centre for Equine Health and Research, Equine Surgery Unit, Veterinary Tissue Engineering and Regenerative Medicine Laboratory, University of Veterinary Medicine Vienna, Vienna, Austria.

Background: Osteoarthritis (OA) remains an intractable condition due to the limited regenerative capacity of adult cartilage. Extracellular vesicles (EVs) have emerged as promising therapeutics, yet the optimal donor cell source is still undetermined, as both donor cell type and age significantly influence EV therapeutic efficacy. This study evaluates the therapeutic potential of EVs derived from ovine fetal articular chondrocytes (fCCs) and ovine fetal umbilical cord blood mesenchymal stromal cells (fMSCs) compared to EVs from two immortalized human perinatal cell lines, Wharton's jelly (WJ-MSCs) and amnion MSCs (P-MSCs), on inflamed ovine adult chondrocytes and synoviocytes in vitro.

View Article and Find Full Text PDF